Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | PARP1 | P09874 | 6/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DDO | Q99489 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9563848 | 0.97 | CYP3A4 (0.43) | CYP3A4SMN1; SMN2PARP1TSHRPOLB | |
| SCHEMBL1807992 | 0.94 | KDM4E (0.46) | CYP3A4SMN1; SMN2PARP1TSHRPOLB | |
| Iodide SCHEMBL9844728 | 0.92 | KDM4E (0.45) | CYP3A4SMN1; SMN2PARP1TSHRPOLB | |
| SCHEMBL6093788 | 0.85 | CYP3A4 (0.39) | CYP3A4SMN1; SMN2PARP1TSHRPOLB | |
| SCHEMBL3661752 | 0.85 | DHODH (0.57) | CYP3A4SMN1; SMN2PARP1TSHRPOLB | |
| SCHEMBL6093183 | 0.85 | CYP3A4 (0.39) | CYP3A4SMN1; SMN2PARP1TSHRPOLB | |
| SCHEMBL6093793 | 0.85 | PARP1 (0.50) | CYP3A4SMN1; SMN2PARP1TSHRPOLB | |
| SCHEMBL15484864 | 0.83 | PARP1 (0.52) | CYP3A4SMN1; SMN2PARP1TSHRPOLB | |
| Ammonia Solution, Strong SCHEMBL20551039 | 0.83 | DHODH (0.55) | CYP3A4SMN1; SMN2PARP1TSHRPOLB | |
| SCHEMBL3090976 | 0.83 | PARP1 (0.52) | CYP3A4SMN1; SMN2PARP1TSHRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116023657-B | Silicon-boron synergistic modified atomic oxygen resistant polyimide composite film and preparation method and application thereof | 中国科学院化学研究所 | 2024-08-20 | — | — | CN | claimed |
| CN-114717751-B | Atomic oxygen-resistant polyimide nanofiber membrane and preparation method and application thereof | 中国地质大学（北京） | 2023-06-20 | — | — | CN | claimed |
| CN-116023657-A | Silicon-boron synergistic modified atomic oxygen resistant polyimide composite film and preparation method and application thereof | 中国科学院化学研究所 | 2023-04-28 | — | — | CN | claimed |
| CN-113416311-B | Phenylethynyl-containing cage type polysilsesquioxane and synthetic method and application thereof | 航天特种材料及工艺技术研究所 | 2022-08-02 | — | — | CN | claimed |
| CN-114717751-A | Atomic oxygen resistant polyimide nanofiber membrane and preparation method and application thereof | 中国地质大学（北京） | 2022-07-08 | — | — | CN | claimed |
| US-20150133628-A1 | POLYAMINE AND METHOD FOR PRODUCING THEREOF | RHODIA OPERATIONS (FR) | 2015-05-14 | — | — | US | claimed |
| US-20130123542-A1 | POLYAMINE AND METHOD FOR PRODUCING THEREOF | RHODIA OPERATIONS (FR) | 2013-05-16 | — | — | US | claimed |
| EP-2522688-A1 | POLYAMINE AND METHOD FOR PRODUCING THE SAME | Rhodia Operations (FR) | 2012-11-14 | — | — | EP | claimed |
| CN-102675637-A | Electrochromatic polyimide and preparation method thereof | UNIV HEILONGJIANG | 2012-09-19 | — | — | CN | claimed |
| EP-2111236-A2 | NOVEL CASCADE POLYMER COMPLEXES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THE SAME | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-10-28 | — | — | EP | claimed |
| US-20080213187-A1 | NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | EPIX PHARMACEUTICALS, INC. | 2008-09-04 | — | — | US | claimed |
| WO-2008087017-A2 | NOVEL CASCADE POLYMER COMPLEXES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THE SAME | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-07-24 | — | — | WO | claimed |
| US-6013760-A | COPOLYMER HAVING SUCCINYL DICARBOXYCYCLOHEXENE DERIVATIVE AND DIAMINOBENZAMIDE DERIVATIVE UNITS; PROCESSABILITY | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2000-01-11 | — | — | US | claimed |
| US-20260071029-A1 | POLYIMIDE PRECURSOR COMPOSITION, POLYIMIDE FILM AND POLYIMIDE/SUBSTRATE LAMINATE | UBE CORP (JP) | 2026-03-12 | — | — | US | disclosed |
| US-20250312989-A1 | ATOMIC OXYGEN-RESISTANT, LOW DRAG COATINGS AND MATERIALS | SKEYEON INC (US) | 2025-10-09 | — | — | US | disclosed |
| WO-2025121249-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-06-12 | — | — | WO | disclosed |
| US-4095028-A | PROPHYLAXIS, ALLERGIES | THE UPJOHN COMPANY (US) | 1978-06-13 | — | — | US | disclosed |
| US-4089973-A | Cyano phenylene dioxamic acid compounds used in the treatment of allergy | THE UPJOHN COMPANY (US) | 1978-05-16 | — | — | US | disclosed |
| US-3993679-A | ANTIALLERGY | THE UPJOHN COMPANY (US) | 1976-11-23 | — | — | US | disclosed |
| US-3953496-A | ANTIPYRETICS, ANTI-ALLERGIC, ANTI-INFLAMMATORY AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071029-A1 | POLYIMIDE PRECURSOR COMPOSITION, POLYIMIDE FILM AND POLYIMIDE/SUBSTRATE LAMINATE | SMC1A, F11, F12 | CYP3A4 3593/4885SMN1; SMN2 520/4885PARP1 117/4885 |
| US-20080213187-A1 | NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PGF, F13A1, F11 | CYP3A4 2325/4885SMN1; SMN2 4092/4885PARP1 114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.